BeStock  
Stocks › Biotechnology › URGN

UroGen Pharma Ltd URGN

US equityMarket cap rank #2953Biotechnology
$27.65 −$4.08 (-12.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.65 0.00%
Open$31.15
Prev close$31.73
Day range$27.57 – $31.90
Volume2.40M
Market cap$1.36B
P/E (TTM)–
Dividend yield–

URGN Stock News

Headlines matching UroGen Pharma Ltd or the URGN ticker, most recent first.

  • A Quick Look at Today's Ratings for UroGen Pharma Ltd(URGN.US), With a Forecast Between $48 to $75Market news · 6 Aug 2026 · Direct mention
  • Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $60 PositiveMarket news · 6 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $75Market news · 21 Aug 2026 · Direct mention
  • Guggenheim Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $42 PositiveMarket news · 22 Jul 2026 · Direct mention
  • TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 22 Jul 2026 · Direct mention
  • Goldman Sachs Maintains UroGen Pharma Ltd(URGN.US) With Hold Rating, Raises Target Price to $44 PositiveMarket news · 16 Jul 2026 · Direct mention
  • Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $50 PositiveMarket news · 16 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $45Market news · 16 Jul 2026 · Direct mention
  • TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $35Market news · 16 Jun 2026 · Direct mention
  • Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $40 PositiveMarket news · 7 May 2026 · Direct mention
  • Urogen Pharma (URGN) Receives a Buy From H.C. WainwrightTipRanks · 27 May 2026 · Direct mention
  • Oppenheimer Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40Market news · 19 May 2026 · Direct mention
  • Ladenburg Thalmann Initiates UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $43Market news · 11 May 2026 · Direct mention
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Raises Target Price to $45 PositiveMarket news · 11 May 2026 · Direct mention
  • H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $40Market news · 23 Apr 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on URGN.

Sign in to join the discussion.

Scroll to Top